Low Dose Edoxaban in Elderly Patients With AF and a History of Stroke
Status:
NOT_YET_RECRUITING
Trial end date:
2030-12-31
Target enrollment:
Participant gender:
Summary
This prospectively enrolled, pragmatic randomized trial aims to investigate whether very low dose edoxaban regimen (15 mg daily) achieves similar edoxaban concentrations as low dose edoxaban regimen (30 mg daily), while maintaining a comparable risk of clinical outcomes and reducing major bleeding in elderly patients with atrial fibrillation and a history of ischemic stroke or transient ischemic attack.
Phase:
PHASE2
Details
Lead Sponsor:
National Taiwan University Hospital
Collaborators:
National Taiwan University Hospital Hsin-Chu Branch National Taiwan University Hospital, Yun-Lin Branch